Barnett MPG, Bermingham EN, McNabb WC, Bassett S, Armstrong KM, Rounce JR, Roy NC 2010. Investigating micronutrients and epigenetic mechanisms in relation to inflammatory bowel disease. Mutation Research 690:71-80
Barnett, PG, Ferguson LR, 2010 Gene-Diet Interactions in Gut Health, Auckland, New Zealand. Meeting report: Fourth Asia-Pacific Nutrigenomics conference , February 21-25, 2010. Biotechnology Journal 5 (9) 913-918.
Danesi F, Philpott M, Huebner C, Bordoni A, Ferguson LR 2010. Food-derived bioactives as potential regulators of the IL-12/IL-23 pathway implicated in inflammatory bowel diseases. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 690:139-144.
Dug Yeo H, Fraser AG, Dryland P and Ferguson LR (2010) Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn's disease within New Zealand. Mutation Research -- Fundamental and Molecular Mechanisms of Mutagenesis 690:116-122
Ferguson LR 2010. Nutrigenomics and inflammatory bowel diseases. Expert Review in Clinical Immunology, 6: 573-583.
Ferguson LR 2010. Chronic inflammation and mutagenesis. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 690: 3-11
Ferguson LR, Hu R, Lam WJ, Munday K, Triggs CM 2010. Tailoring New Zealand foods to match people's genes: opportunities for collaboration. World Review of Nutrition and Dietetics 3: 305-311.
Ferguson LR 2010. Genome-wide association studies and diet. World Review of Nutrition and Dietetics 101: 8-14
Ferguson LR 2010. Interactions between genes and diet in the etiology of colorectal cancer. World Journal of Gastrointestinal Oncology 2: 125-129.
Ferguson LR, Laing W 2010. Chronic inflammation and human disease. Mutation Research: Fundamental & Molecular Mechanisms, Special issue: 690:1-2.
Ferguson LR, Tatham AL, Lin Z, Denny WA 2010. Epigenetic regulation of gene expression as an anticancer drug target. Review in Current Cancer Drug Targets: 11:199-212.
Ferguson LR, Han DY, Fraser AG, Huebner C, Lam WJ, Morgan AR, Duan H, Karunasinghe N 2010. Genetic factors in chronic inflammation: Single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 690:108-115
Ferguson LR, Han DY, Fraser AG, Huebner C, Lam WJ, Morgan AR. IL23R and IL12B SNPs and Haplotypes Strongly Associate with Crohn's Disease Risk in a New Zealand Population. Gastroenterol Res Pract. 2010;2010:539461. Epub 2010 Dec 27. PubMed PMID: 21253534; PubMed Central PMCID: PMC3021847.
Ferguson LR, Smith BG, James BJ. Combining nutrition, food science and engineering in developing solutions to Inflammatory bowel diseases--omega-3 polyunsaturated fatty acids as an example. Food Funct. 2010 Oct;1(1):60-72. Epub 2010 Sep 22. PubMed PMID: 21776456.
Han DY, Fraser AG, Dryland P and Ferguson LR (2010) Environmental factors in the development of chronic inflammation: A case-control study on risk factors for Crohn's disease within New Zealand. Mutat Res-Fundam Mol Mech Mutag 690:116-122.
Huebner C, Petermann I, Lam WJ, Shelling AN, Ferguson LR 2010. Characterization of single-nucleotide polymorphisms relevant to inflammatory bowel disease in commonly used gastrointestinal cell lines. Inflammatory Bowel Diseases 16(2): 282-95.
Knoch B, McNabb WC & Roy NC (2010). Influence of polyunsaturated fatty acids on intestinal barrier function during colitis. Agro FOOD Industry High-tech 21:29-31.
Knoch B, Barnett MPG, Cooney J, McNabb WC, Barraclough D, Laing W, Zhu ST, Park ZA, McLean P, Knowles SO, Roy NC 2010. Molecular characterization of the onset and progression of colitis in inoculated interleukin-10 gene-deficient mice: a role for PPAR_. PPAR Research 2010:621069
Knoch B, Barnett MPG, McNabb WC, Zhu ST, Park ZA, Khan A, Roy NC 2010. Dietary arachidonic acid-mediated effects on colon inflammation using transcriptome analysis. Molecular Nutrition and Food Research 54: S62-S74.
Knoch B, Nones K, Barnett MPG, McNabb WC and Roy NC (2010) Diversity of caecal bacteria is altered in interleukin-10 gene-deficient mice before and after colitis onset and when fed polyunsaturated fatty acids. Microbiology 156:3306-3316.
Knoch B, Barnett MPG, Cooney J, Barraclough D, Laing W, McNabb WC, Roy NC 2010. Dietary oleic acid as control fatty acid for polyunsaturated fatty acid intervention studies: a transcriptomics and proteomics investigation using interleukin-10 gene-deficient mice. J. Biotechnology 5: 1226-40.
Lin HM, Barnett MP, Roy NC, Joyce NI, Zhu S, Armstrong K, Helsby NA, Ferguson LR, Rowan DD 2010. Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn's disease. Journal of Proteome Research 9:1965-75.
Lin, H.-M., N. A. Helsby, et al. (2010). "Using metabolomic analysis to understand Inflammatory Bowel Disease." Inflamm. Bowel Disease: 1-9.
Morgan AR, Han DY, Huebner C, Lam WJ, Fraser AG, Ferguson LR 2010. PTPN2 but not PTPN22 is associated with Crohn's disease in a New Zealand population. Tissue Antigens, 76:119-125
Morgan AR, Han DY, Lam WJ, Fraser AG, Ferguson LR 2010. Association analysis of 3p21 with Crohn's disease in a New Zealand population. Human Immunology. 71: 602-609
Morgan AR, Thompson JM, Murphy R, Black PN, Lam WJ, Ferguson LR, Mitchell EA. Obesity and diabetes genes are associated with being born small for gestational age: results from the Auckland Birthweight Collaborative study. BMC Med Genet. 2010 Aug 16;11:125. PubMed PMID: 20712903; PubMed Central PMCID: PMC2928774.
Nolan DJ, Han DY, Lam WJ, Morgan AR, Fraser AG, Tapsell LC, Ferguson LR. Genetic adult lactase persistence is associated with risk of Crohn's Disease in a New Zealand population. BMC Res Notes. 2010 Dec 19;3:339. PubMed PMID: 21167073; PubMed Central PMCID: PMC3020180.
Rakhshandehroo M, Knoch B, MÃ¼ller M, Kersten S (2010). Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010;2010. pii: 612089.
Rush EC, Cumin MB, Migriauli L, Ferguson LR, Plank LD. One year sustainability of risk factor change from a 9-week workplace intervention. J Environ Public Health. 2009;2009:569104. Epub 2010 Feb 10. PubMed PMID: 20169118; PubMed Central PMCID: PMC2821637.
Russ AE, Barnett MPG, McNabb WC, Anderson RC, Reynolds GW, Roy NC 2010. Post-weaning effects of milk and milk components on the inflamed intestinal mucosa. Mutation Research 690: 64-70
Tian H, Maddox IS, Ferguson LR, Shu Q 2010. Evaluation of the cytoprotective effects of bovine lactoferrin against intestinal toxins using cellular model systems. Biometals. 23: 589-592.
Tian H, Maddox IS, Ferguson LR, Shu Q 2010. Influence of bovine lactoferrin on selected probiotic bacteria and intestinal pathogens. Biometals. 23: 593-596
Tian H, Maddox IS, Ferguson LR, Shu Q. Influence of bovine lactoferrin on selected probiotic bacteria and intestinal pathogens. Biometals. 2010 Jun;23(3):593-6. Epub 2010 Mar 9. PubMed PMID: 20217186.
Triggs CM, Munday K, Hu R, Fraser AG, Gearry RB, Barclay ML, Ferguson LR 2010. Dietary factors in chronic inflammation: Food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population. Mutation Research. 690:123-138